Alpha galactosidase in leucocytes
Material: | 6 ml EDTA-blood Dispatch on the same day |
Methods: | Spektrometrie → UV- / VIS-Photometrie | Reference range | 14,0 nmol/h/mg – 72,6 nmol/h/mg |
Indication | Suspicion of Fabry’s disease |
Please note | Fabry’s disease is a sphingolipid storage disorder, caused by alpha galactosidase deficiency. Incidence is 1:40.000, pattern of inheritance is technically X-chromosomal recessive, however due to accidental X-inactivation in individual cells, women may also be affected, however usually with a milder course of illness. Painful neuropathy (palms, soles, “appendicitis”, “renal colic”) in young men, furthermore angiokeratoma (trunk, perineal region) and hypohidrosis. Life expectancy in untreated patients is limited (on average 55 years in men and 70 years in women). Limiting factors are mainly nephrological and cardiovascular complications (progressive kidney failure, cardiomyopathy arrhythmia, cerebral seizure). In men, the evaluation of alpha galactosidase in leukocytes is decisive in diagnostics (enzyme activity usually < 1 % of the norm). In up to one third of women however, normal enzyme activity is seen, hence why sequencing of the GLA gene is definitely required. |
External services | ja Medizinisches Labor Bremen |
More Results for the letter A
- Angina Plaut-Vincenti (APV)
- Treponema vincentii and fusobacterium nucleatum
- ANP (ANP)
- atrial natriuretic peptide
- Anti-actin autoantibodies (ACTIN)
- Anti-alpha fodrin autoantibodies (AFODG)
- Anti-desmoglein 1/3 (DESMO)
- Anti-DNA antibodies (DNADS)
- ds-DNA antibodies (double-stranded)
- Anti-epidermal basal membrane (EPI)
- Anti-goblet cell autoantibodies (BECZE)
- Anti-mitochondrial antibodies (AMA)
- AMA and AMA subtype 2
- Anti-mullarian hormone (AMH)
- Anti-sickle cell desmosomes (STADE)
- Anti-SP100 (SP100)
- multiple nuclear dots
- Antibiogram (ANTIBIO)
- Antibodies against α-amino-3-hydroxy-5-methyl-4-isoxazol-propionic acid receptor (AMPAR)
- Antibodies against adenylate kinase 5 (Ak5)
- Ak5
- Antibodies against contactin-associated protein 2 (CASPR2)
- Antibodies against ganglionic (alpha-3) acetylcholine receptors (gAChR)
- (gAChR)
- Antibodies against glutamate decarboxylase 65 kDa (GAD65)
- Antibodies against leucine-rich glioma inactivated protein 1 (LGI1)
- Antibodies against LRP4
- (low-density lipoprotein receptor-related protein 4)
- Antibodies against myelin oligodendrocyte glycoprotein (MOG)
- Antibodies against N-methyl-D-aspartate receptor receptors (NMDAR)
- Antibodies against oxidized LDL (LDLOX)
- Antibodies against the γ-aminobutyric acid A receptor (GABA-A-R)
- Antibodies against the γ-aminobutyric acid B receptor (GABA-B-R)
- Antibodies against the glial fibrillary acidic protein (GFAP)
- Antibodies against the glycine receptor (GlyR)
- Antibodies against the metabotropic glutamate receptor type 1 (mGluR1 antibodies)
- Antibody screen (ANTI01)
- Antibody screening (AK)
- AKS